Milestone Pharmaceuticals Inc.
MIST
$1.69
-$0.01-0.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -42.99% | 84.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -38.94% | 66.21% | |||
| Operating Income | 38.94% | -66.21% | |||
| Income Before Tax | 37.55% | -67.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 37.55% | -67.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 37.55% | -67.93% | |||
| EBIT | 38.94% | -66.21% | |||
| EBITDA | 39.00% | -66.34% | |||
| EPS Basic | 37.64% | -67.94% | |||
| Normalized Basic EPS | 37.64% | -67.92% | |||
| EPS Diluted | 37.64% | -67.94% | |||
| Normalized Diluted EPS | 37.64% | -67.92% | |||
| Average Basic Shares Outstanding | 0.14% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.14% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||